RxDoctor Payments Data

Vinayak Dongre, MD

Family Medicine · Plainfield, ILNPI 1326193541

Payments from drug & device makers

$7,535in general payments, 2019–2025

Across 143 payments — averaging $52.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mimedx Group, Inc.$2K
  • AstraZeneca$2K
  • Novo Nordisk$412
  • Surgenex LLC$400
  • Lilly USA, LLC$376
  • Amarin Pharma, Inc.$362
  • plus $3K from 22 others

What the payments were for

  • Consulting fees$81611%
  • Travel & lodging$81311%
  • Food & beverage$5,59774%
  • Education$471%
  • Other$2623%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,535 in reported general payments places this provider in the 90th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$159,114
Medicare patients
204
Services billed
1,434

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SantylCollagenase Clostridium Hist.28$11,872
JardianceEmpagliflozin12$11,550
Arnuity ElliptaFluticasone Furoate13$3,593
Gentamicin Sulfate35$1,267
SynthroidLevothyroxine Sodium16$811
Betamethasone Valerate34$725
Telmisartan13$606
Atorvastatin Calcium58$545
Albuterol Sulfate HfaAlbuterol Sulfate15$472
Metoprolol Succinate24$432
Gabapentin12$329
Levothyroxine Sodium35$266
Finasteride19$255
Glipizide ErGlipizide15$238
Amlodipine Besylate32$236

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Smith+NephewSantyl$328$11,87228 claims
Boehringer IngelheimJardiance$88$11,55012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Plainfield

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →